Alan .. post of mine just now on the IPIX SMB here .. to Mo

New Post Public Reply Private Reply Replies (0) Message Board
4kids AlanC #3698
711
Alan .. post of mine just now on the IPIX SMB here .. to Mo in response to a
query ..


https://investorshangout.com/post/view?id=5039720

============

Mo ..

First apologies for my delayed response .. was away for the past 3 days for a long planned for family event .. and there is never enough time in the day some days ..

One of the aspects of observing/documenting OTC *activity* is the learning that comes from that in conjunction with making phone calls .. not just to company IRs .. or Finra or the SEC .. but to TA (transfer agents) too .. something i've done for years

The way it usually works when shares are issued to an entity .. is the monies are first collected by the TA .. then the cert is cut and then transferred .. that is why imo while *shares* can be worked off in advance of issuance and transfer by the usual suspects .. we see a timeline *imo* re: IPIX *volume* kick in on the 9th of April .. it's also very telling *imo* that mgmt got in front of *imo* >> a *known* perceived negative (shares potentially hitting the tape) and 8k'd the PR issued on 4.9.18 .. (see below)

now what some may or may not know .. is you can see what is reported by actual MMs .. to Finra every month .. this data comes out usually by about the 7th to 10th of the following month .. so for April 2018 (remember tho' date noted in filing
was 4.1.18 .. that was a Sunday .. with first *potential* date for selling on 4.2.18 .. which imo was not reality based on the usual time lines known and tapes of trades for that first week and volume for 10 day noted on the morning of 4.9.18 at just over 90,000)

4.9.2018 .. IPIX Volume 382,840
Volume (10 Day Average) 90,757
Volume (90 Day Average) 246,670


MMs' MM Monthly April 2018 reported 4,473,436 .. now the way this works is to cut that number in half .. because half of total reported are shares bought and half of what are reported are shares sold (4,473,436 divided by 2 = 2,236,718 )

http://otce.finra.org/MonthlyShareVolume

https://finance.yahoo.com/quote/IPIX/history?...equency=1d

since the start of May .. (yahoo will round off) .. so I went back to my screenshots pulled each day since May 1st thru Friday (5.11.18) .. for actual numbers

5.1.2018 .. IPIX Volume 191,629
Volume (10 day Average) 266,416
Volume (90 day Average) 211,766

5.2.2018 .. IPIX Volume 248,670
Volume (10 day Average) 258,993
Volume (90 day Average) 211,429

5.3.2018 .. IPIX Volume 161,353
Volume (10 day Average) 256,793
Volume (90 day Average) 211,136

5.4.2018 .. IPIX Volume 200,005
Volume (10 day Average) 222,038
Volume (90 day Average) 211,292

5.7.2018 .. IPIX Volume 578,397
Volume (10 Day Average) 211,721
Volume (90 Day Average) 211,839

5.8.2018 .. IPIX Volume 185,071
Volume (10 day Average) 235,332
Volume (90 day Average) 216,329

5.9.2018 .. IPIX Volume 655,074
Volume (10 day Average) 229,990
Volume (90 day Average) 213,938

5.10.2018 .. IPIX Volume 522,474
Volume (10 day Average) 281,349
Volume (90 day Average) 217,466

5.11.2018 .. IPIX Volume 360,275
Volume (10 day Average) 319,602
Volume (90 day Average) 220,187


I show Volume total currently for May 2018 based on the above = 3,102,948 .. divided by 2 = 1551,474 ..

1,551,474 (May currently) + 2,236,718 for April 2018 = 3,788,192 *sells*


Realize that that may not be all the one entity selling .. note the *high* re: PPS achieved on 4.9.18 (63c and the most recent *high* on IPIX for weeks) .. *imo* first day of entity selling (again entity's known awareness of *access* to those forthcoming shares allows for all sorts of games to be played out) .. we see the PPS taken to 63c .. pre reset back down .. the day mgmt 8k'd this PR .. volume that day with a *liquidity* range of 8c *imo* allows for the possibility of those who trade also being in play then

Apr 09, 2018 0.61 0.63 0.55 0.58 0.58 391,300

April 9, 2018
INNOVATION PHARMACEUTICALS PHASE 2 ORAL MUCOSITIS TRIAL ADDITIONAL DATA SHOW BRILACIDIN-OM DEMONSTRATED A SIGNIFICANT REDUCTION IN THE INCIDENCE OF SEVERE ORAL MUCOSITIS...

http://www.ipharminc.com/press-release/

so entity has a ways to go *imo* based on 8M *available* and known sells of (possibly and probably not all of theirs) 3,788,192 by COM on 5.11.18 .. entity may not *sell* every *share* available .. based on what Mgmt noted subsequent to 4.9.18

May 9, 2018
INNOVATION PHARMACEUTICALS CONCLUDES DATA ANALYSIS OF ITS PHASE 2 CLINICAL TRIAL FOR SEVERE ORAL MUCOSITIS IN HEAD AND NECK CANCER; POSITIONING TO FILL A SUBSTANTIAL VOID IN SUPPORTIVE CANCER CARE

April 23, 2018
INNOVATION PHARMACEUTICALS SIGNS DRUG SUPPLY CONTRACT WITH EVONIK TO BULK PRODUCE COMMERCIAL-GRADE BRILACIDIN

April 16, 2018

INNOVATION PHARMACEUTICALS DATA FROM PHASE 2 BRILACIDIN ORAL MUCOSITIS (OM) TRIAL IN HEAD AND NECK CANCER SHOW NOTABLE REDUCTIONS IN MEDIAN DURATION OF SEVERE OM AND IN NUMBER OF UNPLANNED VISITS...

and filed ..

http://www.ipharminc.com/financials/

one last fact .. re: data that has always threatened NR since link first went live back in Feb 2010 .. having noted this data since i first invested in this *imo* OTC Survivor .. since 4.2.18 .. the *days that IPIX has been marked*

@ sub 30% are 3

the days that IPIX has been marked

@ plus 30% are 12
@ plus 40% are 9 (including 5/9 and 5/11)
@ plus 50% are 6 (including 5/8 and 5/10)


out of those 30 days (total) .. i am not including the handful of days that pre mkt or ah trades went off .. that do bypass those %s being *marked* by MMs ..

%s having to be *marked* higher are morphing up the food chain .. something when understood in aggregate and in comparison to prior *time lines and NR efforts* is understandable as to why it threatens

i hope this helps .. i'd planned to expound on *imo* a few options MMs may undertake on IPIX going forward ..

i did not see most of Friday's *trading* live as i was traveling .. but i can watch today and will see if one of the 3 options i'd noted in this venue previously looks to be in play ..

this is what i refer to a *partially laddered take up* .. when % reset back down is less than the % reset back up .. imo in NRs' *shoes* .. it's the option i'd undertake

if this is the option chosen by NR .. we will still see a significant % marked each day and *legal* short reported .. imo will remain hovering along @ the 1M to 1.3M

*legal* (dated data) next report due out ah's on 5.24.18


http://www.finra.org/industry/short-interest/...-due-dates


4kids
Quote:


Please check my math on shares sold from 4/2/18 thru 5/9/18. I added up the total shares sold on the attached from 4kids and it came out to 6,690,500 shares sold. 4kids also mentions that the following volumes as of 5/9/18.
Volume (10 day Average) 229,990
Volume (90 day Average) 213,938

Per the 10Q IPIX sold 8M shares or an average of 285,714 shares/day through Aspire in that same period. I realize that none of us know the exact amount that Aspire sold on the open market but as mentioned by Sox, we know that Aspire has never filed a 13G indicating they own less than 5% or 7M shares of IPIX stock. The stock price dropped 30% from .51 to .36 during this period. So we know that Aspire held on to at least 1.3M shares (8M-6.69M) but represented a vast majority of the supply of shares available for sale during this period.
I am not stating that I don’t believe there are not criminal entities trying to cripple IPIX, as it is obvious that some entity with deep pockets has been funding the manipulation of the stock price going back to the orchestrated Mako/Rosen attack and has continued to date There are obvious shorting cabals but these guys are small players in the big picture and are again probably being paid off by an entity that either has competing drugs or is trying to buy IPIX assets cheaply. So to those that have argued whether it has been Aspire pressure on a thinly traded pre-revenue stock vs those that believe illegal activities including NSS, my position is that you are both right. It has been a layup for the short sellers UP TO THIS POINT. Science wins at the end and a partnership is a validation stamp and the end of dilution.
It has been painful to watch the share price spiral downward but there have been several “tells” that IPIX has communicated that tell me that:
- A B-OM deal is as good as done (negotiation stage) and will be finalized after the P results are known.
- P results have very good odds of being positive and there could be a P partnership very soon as well.
- Either of the above or possibly both will make the Aspire deal unnecessary going forward. (No more dilution)
- IPIX is exploring new facilities for corporate Headquarters. Over the next year company plans on increasing all areas of administration to include employees and facilities. If you were CEO why would you possibly do this unless you were positioning for major growth?
- IPIX has $2M in the bank ($1.3M cash plus $2M Aspire sales less $1M owed to CRO) and Leo has delayed any unnecessary expenditures.
- Evonik deal in place to produce B-OM packaging and probable B-UP foam etc. Would you sign a drug manufacturing contract if a deal wasn’t close?
- I haven’t even mentioned K which if successful could make IPIX a triple digit stock.
For a more complete list regarding the science check out posts by Drano, Sox, DaubersUP and others. The next few weeks should be exciting . GLTA longs,

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 137

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 410

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 666

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 518

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 98

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 530

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 332

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 45

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading

Top 5 Most Recently Viewed Articles

Eaton Corp's Options Trading Insights and Market Analysis

Updated Category News Views 116

Understanding Eaton Corp's Options Trading Trends Recently, financial analysts have noticed a significant bearish trend when it comes to options trading for Eaton Corp (NYSE: ETN). Investigating the history of options trades has revealed insights into the market sentiment surrounding this industrial giant. A thorough analysis showed that a mere 11% of traders exhibited...

Continue Reading
Celebrating Community Resilience After Pacific Palisades Fires

Updated Category News Views 207

Community Resilience Shines in Pacific Palisades The recent reopening of the Casa Gateway affordable housing complex in Pacific Palisades brings a heartwarming sense of relief to many residents who faced the devastating impact of fires. Amidst the recovery efforts, stories of gratitude and hope shine through, demonstrating the importance of community support and...

Continue Reading
Stellantis Makes Bold Move with $41 Million Investment for Efficiency

Updated Category News Views 225

Stellantis Invests $41 Million for Enhanced Parts Delivery Stellantis (NASDAQ: STLA), the parent organization of popular automotive brands such as Jeep and Dodge, is taking significant steps towards improving its logistics capabilities with a substantial $41 million investment. This financial commitment is part of a broader strategy to modernize its parts distribution...

Continue Reading
Navigating the Shifts in Money Market Dynamics and Bank Reserves

Updated Category News Views 137

Understanding Current Dynamics in Money Markets The landscape of liquidity in the money markets is currently characterized by ample conditions. However, experts anticipate a reduction in bank reserves in the months ahead, leading to a potential tightening of conditions. With ongoing activity in market repurchase agreements (repo) and a robust issuance of treasury bills,...

Continue Reading
Harnessing AI and Human Intelligence for Personal Growth

Updated Category News Views 329

AI Happiness Accelerator Empowers Personal Growth Imagine if you could optimize your thoughts and emotions just like improving a website’s performance. The AI Happiness Accelerator (AHA) aims to do exactly that by leveraging cutting-edge Generative AI tools. Co-founder and Chief Information Officer Amy Chang emphasizes that success in all areas—personal, relational,...

Continue Reading